Quarterly and Annual DistributionsBioMed's board of directors previously declared a third quarter 2010 dividend of $0.17 per share of common stock, and a dividend of $0.46094 per share of the company's 7.375% Series A Cumulative Redeemable Preferred Stock for the period from July 16, 2010 through October 15, 2010. The third quarter common share dividend represented a 13.3% increase over the second quarter 2010 dividend, and a 54.5% increase over the third quarter 2009 dividend, and is equivalent to an annualized dividend of $0.68 per common share.
Earnings GuidanceThe company is reporting its fourth quarter 2010 guidance for net income per diluted share and FFO per diluted share to reflect the impact of the recent acquisitions and capital activity. The company's guidance is set forth and reconciled below. Projected FFO per diluted share is based upon estimated, weighted-average diluted common shares outstanding of approximately 144 million for the fourth quarter.Three months endedDecember 31, 2010(Low - High)Projected net income per diluted share availableto common stockholders
$0.07 – $0.08 Add:Noncontrolling interests in operating partnership
$0.00Real estate depreciation and amortization
$0.21 Less:Assumed conversion of senior exchangeable notes due 2030
($0.01)Projected FFO per diluted share
$0.27 – $.0.28The company's fourth quarter 2010 guidance does not include any assumptions related to future financing or investing activities beyond announced transactions, but does include the impact of the assumed conversion of the company's exchangeable senior notes due 2030.
The company's initial 2011 guidance for net income per diluted share and FFO per diluted share is set forth and reconciled below. Projected FFO per diluted share is based upon estimated, weighted-average diluted common shares outstanding of approximately 144 million for the full year,
|SOURCE BioMed Realty Trust, Inc.|
Copyright©2010 PR Newswire.
All rights reserved